CJC-1295 without DAC 5mg + Ipamorelin 5mg Co-Formulated Vial

Product Overview

This is a co-formulated lyophilized vial containing two peptides: Modified GRF (1-29) — commercially listed as CJC-1295 without DAC — at 5mg, and Ipamorelin at 5mg. It is supplied for qualified B2B research sourcing projects. This page describes sourcing and analytical documentation only; it does not describe biological action, combination rationale, end-user application, or product performance.

What to check on a blended vial that you would not check on a single one

• Component-level documentation. The analytical record should distinguish the two components and state clearly how identity and purity were assessed for each. Where a component-specific RP-HPLC purity figure is given, the method needs adequate chromatographic separation to support it — a number reported without that separation does not describe either component well.
• The ratio is part of the specification. 5mg + 5mg and 10mg + 2mg are different products. The ratio belongs in the written specification and on the label, not in a verbal agreement.
• Total weight is not total peptide. Counterion content, residual moisture, and any excipient sit inside the vial weight. On a two-component vial this arithmetic is easier to get wrong, so confirm what the per-vial claim is measured against.
• Which CJC-1295. This specification is Modified GRF (1-29), the non-DAC material. Confirm it on the identity record rather than the trade name.

What Guangzhou Peptide Research Center Can Supply

• Co-formulated vials at the 5mg + 5mg specification as standard
• Alternative ratios and fill quantities by project
• Batch-specific COA distinguishing the two components
• Neutral-label or private-label packaging, with components and ratio stated on the label
• Single-component vials as an alternative — see Modified GRF (1-29) and Ipamorelin
• MOQ, lead time, and phased delivery planning

Quality and Documentation

A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.

Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.

Compliance Note

This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and Guangzhou Peptide Research Center does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.

Frequently Asked Questions

Should a blended vial have one COA or two sets of results?

One COA is fine, but it should distinguish the components and say how identity and purity were assessed for each. A single combined purity figure does not adequately describe the purity of either component.

Can a component-specific purity always be reported?

Only where the analytical method separates the two peptides well enough to support it. Ask what method was used before treating two percentages as equivalent to two single-component COAs.

Can the ratio be changed?

Yes, alternative ratios and fill quantities are set per project. Whatever is agreed should appear in the written specification and on the vial label.

What should I send to get a quotation?

Company and business type, destination market, intended business use, required documentation package, target ratio and fill quantity, vial count, packaging preference, and required timeline.

Specification and documentation references

• Lyophilized vial sourcing guide — fill amount, packaging, MOQ and documentation.
• What a 10mg vial actually contains — peptide content, counterion, moisture and excipients.
• How peptide identity is confirmed by mass spectrometry — what an identity record can and cannot establish.